GHK-KPV refers to a research pairing of two short, well-characterized peptide motifs: GHK (glycyl-L-histidyl-L-lysine), the copper-binding tripeptide, and KPV (L-lysine-L-proline-L-valine), a C-terminal fragment associated with regulatory signaling. Joined into a single chain, it is used as a laboratory tool to study whether the two sequences produce complementary readouts within one model system.
What it is
Each component is a small peptide whose sequence can be interpreted using general amino acid sequence principles. GHK is best known from copper-peptide research, where its metal-binding chemistry has been studied for decades, while KPV is examined separately in the KPV overview. GHK-KPV brings both into a single construct.
Why researchers pair the motifs
The rationale for co-formulated tool compounds is that distinct motifs may engage different chemistry — in this case copper coordination on one side and regulatory signaling on the other. The broader logic of such combinations is discussed in peptide blends and research stacks. The proposed mechanism of action treats the two fragments independently.
How it is made and verified
For research supply, the hybrid is assembled by solid-phase synthesis and confirmed for identity and purity; its construction is described in structure and synthesis.
Research context
Reproducibility depends on documented identity and purity — see how to read a COA. Findings from GHK-KPV describe controlled laboratory behavior only.
What the hybrid can test
The construct can address a focused experimental question: does covalently linking a metal-binding motif to a regulatory tripeptide change either component’s measurable behavior? Answering it requires comparison with GHK alone, KPV alone, and a noncovalent mixture. Those controls distinguish a true property of the six-residue chain from the simple presence of both parent sequences in the same assay.
Limits of component-based inference
Evidence associated with GHK or KPV should not be transferred automatically to GHK-KPV. Fusion changes molecular mass, terminal groups, local charge, and susceptibility to cleavage, all of which may influence experimental behavior. The hybrid should therefore be characterized as its own research material, with conclusions restricted to the specific in-vitro or preclinical system in which it was tested. Naming conventions also deserve care: a product name does not specify copper occupancy, terminal state, counterion, or whether the motifs are covalently fused. Researchers should consult the sequence and analytical record for the material in hand. Clear molecular identification makes comparisons among publications, suppliers, and experimental batches more reliable.
Product page: GHK-KPV research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.